Related Experiment Video
Updated: Mar 20, 2026
08:55
The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
Published on: November 30, 2016
17.3K
Fn14: a new player in cancer-induced cachexia
Amelia J Johnston1, Nicholas J Hoogenraad
1Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Victoria 3086, Australia.
Summary
Recent cancer cachexia research reveals key molecular drivers, including fibroblast growth factor-inducible 14 and impaired insulin signaling. Understanding these mechanisms is crucial for developing effective therapies for this common cancer complication.
Area of Science:
- Oncology
- Molecular Biology
- Metabolism
Background:
- Cancer cachexia affects up to 80% of cancer patients, characterized by muscle wasting and metabolic disturbance.
- The underlying causes of cancer cachexia have remained largely unknown, hindering therapeutic development.
Purpose of the Study:
- To review recent findings in cancer cachexia research.
- To highlight novel molecular mechanisms implicated in cancer cachexia.
Main Methods:
- Review of recent scientific literature on cancer cachexia.
- Analysis of studies investigating molecular pathways and receptors involved in cachexia.
Main Results:
- Fibroblast growth factor-inducible 14 (FGF14) expression on tumors can initiate cachexia, treatable with antibodies.
- Parathyroid hormone receptor-binding proteins mediate cachexia by altering adipose tissue (white to brown).
- Impaired insulin signaling in Drosophila models suggests a role in cachexia via insulin-binding proteins.
Conclusions:
- Recent research is uncovering the molecular basis of cancer cachexia.
- Identifying these pathways offers potential for new therapeutic strategies.
- Advances in understanding cachexia could improve clinical outcomes for cancer patients.
Related Concept Videos
02:53Adaptive Mechanisms in Cancer Cells
7.3K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K
01:21Cancer Survival Analysis
812
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
812
01:35Cancer Cell Migration through Invadopodia
3.4K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.4K
02:49Cancer Therapies
10.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K
02:49Cancer Therapies
3.0K
3.0K
02:40Cancer Stem Cells and Tumor Maintenance
6.3K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.3K